In just one day, the color drained from Jessica Scarpa’s world. The 36-year-old mother from Olginate noticed her skin and eyes turning yellow, a stark warning sign that led to a devastating diagnosis of metastatic pancreatic adenocarcinoma within hours. What started as a physical symptom became a race against time, leaving a family facing an impossible choice between survival and the unknown.

Jessica Scarpa pancreatic cancer drug access

The cure exists, but it comes with a staggering price tag that most families cannot fathom. The experimental treatment approved by the US FDA costs roughly $39,800 every single month, adding up to nearly half a million dollars annually. For Scarpa, this isn't just a medical bill; it is the literal cost of staying alive long enough to witness future milestones.

Italy’s standard oncology pathways have not yet authorized this therapy, forcing the family to look across the Atlantic for hope. They launched a GoFundMe campaign, and the response was immediate: over 4,000 donors contributed €160,000 in just days. This outpouring of support highlights a gap in European healthcare access, where patients sometimes must rely on global generosity to afford life-saving drugs.

Scarpa’s mission is deeply personal and tied to a specific date on the calendar. She needs to survive until January, when her twins, Thiago and Leone, will finally turn four years old. Her goal is simple yet profound: to ensure she is there to hold their hands and be part of their earliest memories, proving that love can sometimes bridge the gap between life and death.